PE20071004A1 - Composiciones farmaceuticas que comprenden la combinacion de ivabradina y perindropil - Google Patents

Composiciones farmaceuticas que comprenden la combinacion de ivabradina y perindropil

Info

Publication number
PE20071004A1
PE20071004A1 PE2006001619A PE2006001619A PE20071004A1 PE 20071004 A1 PE20071004 A1 PE 20071004A1 PE 2006001619 A PE2006001619 A PE 2006001619A PE 2006001619 A PE2006001619 A PE 2006001619A PE 20071004 A1 PE20071004 A1 PE 20071004A1
Authority
PE
Peru
Prior art keywords
ivabradine
perindropil
combination
pharmaceutical compositions
compositions including
Prior art date
Application number
PE2006001619A
Other languages
English (en)
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20071004(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PE20071004A1 publication Critical patent/PE20071004A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UNA ASOCIACION DE UN INHIBIDOR SELECTIVO Y ESPECIFICO DE LA CORRIENTE SINUSAL I TAL COMO IVABRADINA Y UN AGENTE INHIBIDOR DE CONVERSION DE LA ANGIOTENSINA TAL COMO PERINDOPRIL EN FORMA DE SAL DE TERC-BUTILAMINA O ARGININA EN COMBINACION CON UNO O VARIOS EXCIPIENTES. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE HIPERTENSION ARTERIAL
PE2006001619A 2005-12-21 2006-12-18 Composiciones farmaceuticas que comprenden la combinacion de ivabradina y perindropil PE20071004A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Publications (1)

Publication Number Publication Date
PE20071004A1 true PE20071004A1 (es) 2007-11-17

Family

ID=36685870

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2006001619A PE20071004A1 (es) 2005-12-21 2006-12-18 Composiciones farmaceuticas que comprenden la combinacion de ivabradina y perindropil
PE2010001026A PE20110116A1 (es) 2005-12-21 2006-12-18 Asociacion de ivabradina y perindopril y composicion farmaceutica que la contiene

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2010001026A PE20110116A1 (es) 2005-12-21 2006-12-18 Asociacion de ivabradina y perindopril y composicion farmaceutica que la contiene

Country Status (42)

Country Link
US (2) US20070142355A1 (es)
EP (2) EP1800678B1 (es)
JP (2) JP4705564B2 (es)
KR (2) KR100907583B1 (es)
CN (1) CN101015557B (es)
AP (1) AP2119A (es)
AR (1) AR058574A1 (es)
AT (1) ATE508742T1 (es)
AU (1) AU2006252210B2 (es)
BR (1) BRPI0605517A (es)
CA (1) CA2571644C (es)
CO (1) CO5790168A1 (es)
CR (1) CR8820A (es)
CY (1) CY1111575T1 (es)
DK (1) DK1800678T3 (es)
EA (1) EA011253B1 (es)
ES (1) ES2366570T3 (es)
FR (1) FR2894825B1 (es)
GE (1) GEP20094604B (es)
GT (1) GT200600522A (es)
HK (1) HK1106444A1 (es)
HR (1) HRP20110532T1 (es)
IL (1) IL180204A (es)
JO (1) JO2699B1 (es)
MA (1) MA28723B1 (es)
ME (1) ME01958B (es)
MX (1) MXPA06014885A (es)
MY (1) MY146956A (es)
NO (1) NO337640B1 (es)
NZ (1) NZ552221A (es)
PE (2) PE20071004A1 (es)
PL (1) PL1800678T3 (es)
PT (1) PT1800678E (es)
RS (1) RS51731B (es)
SA (1) SA06270480B1 (es)
SG (2) SG173243A1 (es)
SI (1) SI1800678T1 (es)
TW (1) TWI369206B (es)
UA (1) UA86417C2 (es)
UY (1) UY30023A1 (es)
WO (1) WO2007077327A1 (es)
ZA (1) ZA200610824B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
WO2002100408A2 (en) * 2001-06-08 2002-12-19 Ortho-Mcneil Pharmaceutical, Inc. Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
ATE401082T1 (de) * 2001-09-11 2008-08-15 Asahi Kasei Pharma Corp Medizinische zusammensetzung zur prävention oder behandlung von zerebrovaskulären störungen
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
DK1362590T3 (da) * 2002-07-25 2004-03-29 Boehringer Ingelheim Pharma Anvendelse af cilobradin eller farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
EA200602155A1 (ru) 2007-08-31
AU2006252210A1 (en) 2007-07-05
TWI369206B (en) 2012-08-01
SI1800678T1 (sl) 2011-08-31
NZ552221A (en) 2008-05-30
NO337640B1 (no) 2016-05-23
AP2119A (en) 2010-04-21
PT1800678E (pt) 2011-07-12
US20120196850A1 (en) 2012-08-02
PL1800678T3 (pl) 2011-08-31
MY146956A (en) 2012-10-15
CY1111575T1 (el) 2015-10-07
CO5790168A1 (es) 2007-08-31
UA86417C2 (ru) 2009-04-27
GT200600522A (es) 2007-07-25
IL180204A (en) 2014-02-27
CR8820A (es) 2007-08-28
GEP20094604B (en) 2009-02-10
SG133545A1 (en) 2007-07-30
IL180204A0 (en) 2008-01-20
HK1106444A1 (en) 2008-03-14
DK1800678T3 (da) 2011-08-15
ATE508742T1 (de) 2011-05-15
BRPI0605517A (pt) 2007-10-16
AP2006003859A0 (en) 2006-12-31
CA2571644C (fr) 2011-03-08
KR20090047424A (ko) 2009-05-12
KR20070066921A (ko) 2007-06-27
HRP20110532T1 (hr) 2011-08-31
JP2011079854A (ja) 2011-04-21
KR100907583B1 (ko) 2009-07-14
SA06270480B1 (ar) 2011-02-23
EP2298297A1 (fr) 2011-03-23
UY30023A1 (es) 2007-01-31
JO2699B1 (en) 2013-03-03
EP1800678B1 (fr) 2011-05-11
WO2007077327A1 (fr) 2007-07-12
TW200744608A (en) 2007-12-16
NO20065905L (no) 2007-06-22
FR2894825A1 (fr) 2007-06-22
SG173243A1 (en) 2011-08-29
MA28723B1 (fr) 2007-07-02
FR2894825B1 (fr) 2010-12-03
JP2007169283A (ja) 2007-07-05
PE20110116A1 (es) 2011-03-02
CA2571644A1 (fr) 2007-06-21
CN101015557B (zh) 2010-12-08
EA011253B1 (ru) 2009-02-27
ME01958B (me) 2011-10-31
EP1800678A1 (fr) 2007-06-27
US20070142355A1 (en) 2007-06-21
AR058574A1 (es) 2008-02-13
RS51731B (en) 2011-10-31
JP4705564B2 (ja) 2011-06-22
ES2366570T3 (es) 2011-10-21
CN101015557A (zh) 2007-08-15
ZA200610824B (en) 2008-06-25
AU2006252210B2 (en) 2012-04-26
MXPA06014885A (es) 2009-02-11

Similar Documents

Publication Publication Date Title
PE20071004A1 (es) Composiciones farmaceuticas que comprenden la combinacion de ivabradina y perindropil
PE20142314A1 (es) Composiciones intranasales de dexmedetomidina y metodos de uso de ellas
PE20140978A1 (es) Composicion farmaceutica solida que contiene amlodipina y losartan y el proceso para producirla
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
PE20181523A1 (es) Tratamiento de lupus nefritis usando laquinimod
EA200602221A1 (ru) Новое применение пептидных соединений для лечения боли при тригеминальной невралгии
PE20121442A1 (es) Derivados de oxindol sustituido y composiciones farmaceuticas que los comprenden
CR10748A (es) Compuesto de indol
EA201070544A1 (ru) Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
GT200800158A (es) Pirazolquinolonas como potentes inhibidores de parp
PA8850801A1 (es) Compuestos útiles para inhibir chk1
PE20090605A1 (es) Composiciones de fenilalanina amoniaco-liasa procariotica y metodos del tratamiento del cancer usando composiciones de la misma
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
UA98658C2 (uk) Циклічні депсипептиди
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
AR094074A1 (es) Composiciones que contienen iones de metales estables
TW200738669A (en) Crystalline forms of N-(benzo[b]thien-3-ylmethyl)-sulfamide
CL2011001026A1 (es) Uso de pimobedan para preparar un medicamento util en el tratamiento de cardiomiopatia hipertrofica en un gato.
ATE531721T1 (de) Cyanoaminochinolone als gsk-3-inhibitoren
EA200901406A1 (ru) Чистящий блок для туалета
PE20120019A1 (es) Combinacion de perindopril y n-{[(7s)-3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7-il]metil}-3-(7,8-dimetoxi-1,2,4,5-tetrahidro-3h-3-benzazepin-3-il)-n-metil-3-oxo-1-propanamina
PE20120647A1 (es) Composiciones y metodos para el tratamiento y prevencion de la enfermedad cardiovascular
CY1111588T1 (el) Υποκατεστημενα καρβοξαμιδια ως ανταγωνιστες μεταβολοτροπου υποδοχεα ομαδας ι
FR2943253B1 (fr) Composition contenant l'association de madecassoside, d'une arginine et de polysorbate
ATE474574T1 (de) Imidazoazephinonverbindungen

Legal Events

Date Code Title Description
FC Refusal